Targeting aberrant cell proliferation in brain cancer: Mir-101 inhibits the oncomiR miR-17-92 expression via down regulation of its target gene, 17/December/2013, 8.24 am

Targeting aberrant cell proliferation in brain cancer: Mir-101 inhibits the oncomiR miR-17-92 expression via down regulation of its target gene, 17/December/2013, 8.24 am

Targeting aberrant cell proliferation in brain cancer: Mir-101 inhibits the oncomiR miR-17-92 expression via down regulation of its target gene, 17/December/2013, 8.24 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Targeting aberrant cell proliferation in brain cancer: Mir-101 inhibits the oncomiR miR-17-92 expression via down regulation of its target gene, 17/December/2013, 8.24 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

* Research cooperation

Share
Start Typing